Novo Nordisk Expands Weight-Loss Treatment Options with US Launch of Wegovy Oral Pill
The launch of Wegovy in pill form marks a major step in widening access to obesity treatment in the United
Read More
Factual Version of a Story
obesity treatment
Eli Lilly’s Mounjaro Becomes India’s Top-Selling Drug, Signaling a New Era in Healthcare Innovation
Hyderabad – Eli Lilly’s groundbreaking weight-loss and diabetes treatment, Mounjaro, takes the top spot in India’s pharmaceutical market, marking a
Read More
U.S. Strikes Breakthrough Deal to Boost Access to Weight-Loss Drugs
A landmark public-private partnership aims to make life-changing obesity and diabetes treatments more affordable and accessible for millions across America.
Read More
Pfizer Strengthens Its Bid for Metsera, Reinforces Commitment to Innovation in Obesity Treatment
Pfizer’s strategic move to revise its bid for Metsera underscores its dedication to advancing next-generation obesity therapies and fostering competition
Read More
Novo Nordisk Restructures for Future Growth, Streamlines U.S. Operations to Strengthen Global Efficiency
London — Global healthcare leader Novo Nordisk has taken decisive steps to streamline its U.S. manufacturing operations as part of
Read More